Amgen invests $125 million to expand South San Francisco research hub
أمجين
Amgen Inc. AMGN | 0.00 |
- Amgen invested $125 million to expand its South San Francisco research hub, adding about 50,000 square feet of next-generation small-molecule discovery labs.
- Facility is designed to support more than 100 scientists, with high-throughput automation, robotics, advanced analytical tools.
- Expansion consolidates medicinal chemistry, biology, protein sciences, automation, assay development, data science to accelerate Design-Make-Test-Analyze cycles.
- Goal is to shorten timelines in early discovery, improve candidate selection, raise throughput for small-molecule programs.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Amgen Inc. published the original content used to generate this news brief on May 06, 2026, and is solely responsible for the information contained therein.
